Insurers, banks lead UK stocks lower; US jobs data on tap

Published 01/10/2025, 05:56 AM
Updated 01/10/2025, 06:02 AM
© Reuters. FILE PHOTO: A man walks past the London Stock Exchange in London, Britain, May 14, 2024. REUTERS/Hannah McKay/File Photo
UK100
-
FLG
-

(Reuters) - British equities slipped on Friday, with financial sectors such as insurance and lenders leading losses ahead of the U.S. jobs data, due later in the day, which could offer clues on the Federal Reserve's interest rate trajectory for the year. 

The blue-chip FTSE 100 slipped 0.2% as of 1029 GMT but was set for its third straight weekly advance. The more economically-sensitive midcaps dipped 0.5%, hovering near its lowest level in over eight months.

Insurers dropped 2%, with those having a large exposure to the Los Angeles wildfires such Beazley and Hiscox (LON:HSX) leading losses. Banks lost 0.9%. 

Oil and gas was a bright spot, adding 1.2% as crude prices ticked higher. [O/R]

Investors were mainly focused on the U.S. nonfarm payrolls report, which is expected to show job growth likely slowed to a still-healthy clip in December while the unemployment rate held steady at 4.2%, reinforcing the Fed's cautious approach toward interest rate cuts this year.

Mid-cap stocks have been pressured by a sharp rise in British borrowing costs this week on concerns about high borrowing in Britain and higher taxes on businesses planned by finance minister Rachel Reeves.

Yields on UK government bonds remained elevated on Friday, with the one on the 10-year gilt hovering near its highest level since 2008, while the 30-year stood at its highest level since 1998.

© Reuters. FILE PHOTO: A man walks past the London Stock Exchange in London, Britain, May 14, 2024. REUTERS/Hannah McKay/File Photo

Among individual stocks, Alliance Pharma (LON:ALAPH) jumped 38% after it agreed to be acquired by asset management firm DBAY Advisors in an all-cash deal valuing the healthcare group at 349.7 million pounds ($429.6 million).

Chemicals group Croda (LON:CRDA) lost 2.1% after Morgan Stanley (NYSE:MS) downgraded the stock to "equal-weight" rating from "overweight".

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.